DHEA / DHEA-S Test Explained: Normal Range by Age, High & Low Levels, PCOS & Adrenal Function (India 2026) | DHEA टेस्ट गाइड
DHEA / DHEA-S Test Explained: Normal Range by Age, High & Low Levels, PCOS & Adrenal Function (India 2026)
DHEA टेस्ट गाइड: Age-Wise Normal Range, DHEA vs DHEA-S, High Levels in PCOS, Low Levels in Adrenal Insufficiency, Hirsutism & Androgenisation — पूरी जानकारी
Your gynaecologist has ordered a DHEA-S test as part of a PCOS (polycystic ovary syndrome) hormone panel, or your endocrinologist is investigating excessive body hair, acne, and irregular periods with a battery of androgen tests including DHEA-S and testosterone. Or your report shows "DHEA-S: 498 µg/dL" and your reference range shows an upper limit of 380 — and you are trying to understand whether this elevation is serious, what it means for your health, and what will be done about it. DHEA (Dehydroepiandrosterone) and DHEA-S (DHEA sulphate) are the most abundant steroid hormones produced by the adrenal glands — serving as the primary precursor molecules from which the body manufactures sex hormones (testosterone, oestrogen, and other androgens) in peripheral tissues. Understanding the DHEA-S test is particularly important for Indian women, who have among the world's highest rates of PCOS (estimated 20–30% of Indian women of reproductive age) — a condition where excess adrenal and ovarian androgens, often including elevated DHEA-S, drive the characteristic features of hirsutism, acne, irregular periods, and fertility challenges.
For related hormone tests, see our guides on Female Hormones (LH/FSH/Prolactin), Testosterone, and AMH. For reading lab reports generally, see our beginner's guide.
Gynaecologist ने PCOS hormone panel में DHEA-S test order किया, या excessive body hair/acne/irregular periods की investigation में androgen panel में DHEA-S है। Report में "DHEA-S: 498 µg/dL" है, upper limit 380 — serious है? Health के लिए क्या मतलब? DHEA (Dehydroepiandrosterone) और DHEA-S = adrenal glands द्वारा produce होने वाले most abundant steroid hormones — sex hormones (testosterone, oestrogen) के primary precursor। India में PCOS के extraordinarily high rates (estimated 20–30% women of reproductive age) — PCOS में excess adrenal + ovarian androgens (DHEA-S elevated) = hirsutism, acne, irregular periods, fertility challenges।Table of Contents / विषय सूची
- What Is DHEA and DHEA-S? / DHEA क्या है?
- DHEA vs DHEA-S — Why DHEA-S Is Measured
- Normal Range by Age and Sex
- High DHEA-S — Causes & Clinical Significance
- Low DHEA-S — Causes & Clinical Significance
- DHEA-S in PCOS — India Context
- DHEA-S as Adrenal vs Ovarian Source Marker
- Test Preparation / टेस्ट की तैयारी
- Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
What Is DHEA and DHEA-S?
Dehydroepiandrosterone (DHEA) is a C-19 steroid hormone produced primarily by the zona reticularis of the adrenal cortex, with minor contributions from the ovaries (in women) and the testes (in men). DHEA is a weak androgen itself — it has only about 10% of the androgenic potency of testosterone — but it serves as the critical precursor from which more potent androgens (testosterone, dihydrotestosterone/DHT) and oestrogens (oestradiol, oestrone) are synthesised in peripheral tissues through a process called intracrinology or local steroidogenesis.
DHEA (Dehydroepiandrosterone) = C-19 steroid hormone, primarily adrenal cortex (zona reticularis) द्वारा produce। Minor contributions: ovaries (women), testes (men)। DHEA = weak androgen (testosterone की ~10% potency) — लेकिन critical precursor जिससे peripheral tissues में more potent androgens (testosterone, DHT) और oestrogens (oestradiol, oestrone) synthesise होते हैं (intracrinology / local steroidogenesis)।- The steroidogenesis pathway: All steroid hormones begin from cholesterol. In the adrenal cortex: Cholesterol → Pregnenolone → DHEA → Androstenedione → Testosterone → Oestradiol. DHEA is approximately halfway along this pathway — it is downstream from the early steps (cholesterol and pregnenolone) but upstream of the most biologically active sex hormones.
- The "pool" concept: The body uses DHEA-S as a large, stable, circulating pool of androgen precursor — DHEA-S is essentially a sulphate-conjugated storage form of DHEA. Peripheral tissues can cleave the sulphate group (using the enzyme steroid sulphatase) to regenerate free DHEA, which then enters the local androgen or oestrogen synthesis pathway according to the tissue-specific enzyme profile. This local conversion means that DHEA-S blood levels reflect the total potential androgen load available to the body, not just the circulating active androgen.
- Regulation: DHEA-S production is regulated primarily by ACTH (adrenocorticotrophic hormone from the pituitary) — the same hormone that regulates cortisol production. However, the DHEA-S response to ACTH is less tight than the cortisol response, and other factors (including insulin, IGF-1, and sex steroids) modulate DHEA-S production independently. In PCOS, elevated insulin (from insulin resistance) stimulates adrenal DHEA-S production — explaining why DHEA-S is elevated in many PCOS patients.
DHEA vs DHEA-S — Why DHEA-S Is Measured
In clinical practice, DHEA-S (the sulphate conjugate) is measured rather than free DHEA for several important laboratory and clinical reasons:
- Stability: DHEA-S has a half-life of approximately 8–11 hours — much longer than free DHEA (approximately 20–30 minutes). This means DHEA-S blood levels are far more stable throughout the day and are not subject to the pulsatile fluctuations that make free DHEA measurements unreliable.
- No diurnal variation: DHEA-S does not show significant circadian rhythm variation (unlike cortisol, which varies substantially between morning and evening). DHEA-S can be measured at any time of day with consistent results.
- Volume: DHEA-S circulates at concentrations 100–500 times higher than free DHEA, making it much easier to measure accurately with standard immunoassay techniques.
- Adrenal-specificity: DHEA-S is produced almost exclusively by the adrenal cortex — there is essentially no DHEA sulphotransferase activity in the ovaries or testes, so DHEA-S specifically reflects adrenal androgen production.
- When free DHEA is measured: Free DHEA is occasionally measured in specific research or specialist contexts (e.g., adrenal steroid profiling) but is not part of routine clinical practice. Most labs and clinical guidelines refer to DHEA-S when they order the "DHEA" test — always check your report's exact test name.
DHEA-S is reported in different units depending on the assay platform and lab — this is a common source of confusion for patients:
- µg/dL (micrograms per decilitre): The most commonly used unit in India. Example: "DHEA-S: 285 µg/dL." Reference ranges in µg/dL vary by age and sex (see table below).
- µmol/L (micromoles per litre): The SI unit used by some labs. Conversion: µg/dL × 0.02714 = µmol/L. Example: 285 µg/dL = approximately 7.7 µmol/L.
- ng/mL: Occasionally used. Conversion: µg/dL × 10 = ng/mL. Example: 285 µg/dL = 2,850 ng/mL.
- Key rule: Always use the reference range printed on your specific lab report — do not compare your value to a range from a different lab or a different unit. DHEA-S reference ranges vary between assay platforms and between laboratories.
Normal Range by Age and Sex
*Reference ranges for DHEA-S vary between assay platforms and between laboratories. The values below represent approximate consensus ranges widely used in Indian NABL-accredited labs. Always use the reference range on your specific report. Units: µg/dL. Note that normal ranges for Indian populations may differ from Western reference ranges — age-matched Indian population norms are preferable but not universally established for all labs.
| Age Group | Women (µg/dL) | Men (µg/dL) | Clinical Notes |
|---|---|---|---|
| Children (under 6) | 5–55 | 5–55 | Pre-adrenarche — zona reticularis undeveloped. Very low DHEA-S expected. Significantly elevated DHEA-S in a young child warrants investigation for congenital adrenal hyperplasia or adrenal tumour. |
| Ages 6–12 (adrenarche) | 15–260 | 15–260 | Adrenarche — progressive DHEA-S rise as zona reticularis matures, independent of gonadarche. Pubarche (pubic hair) and axillary hair in girls is driven by DHEA-S. |
| Ages 13–17 (puberty) | 65–380 | 75–420 | Continuing adrenarche rise through puberty. DHEA-S contributes to pubertal acne and early body hair development in both sexes. |
| Ages 18–30 (peak) | 100–430 | 160–560 | Peak DHEA-S production period. Individual variation is very wide. Values above the upper limit in this age group in women should be investigated for PCOS, adrenal hyperplasia, or adrenal tumour. |
| Ages 31–40 | 80–380 | 120–490 | Decline has begun but levels still substantial. PCOS evaluation in this age group should always include DHEA-S. |
| Ages 41–50 | 60–310 | 90–380 | Significant decline — approximately 30–40% below peak. Perimenopausal women may experience symptoms of DHEA deficiency (fatigue, reduced libido, vaginal dryness) as adrenal and ovarian production both fall. |
| Ages 51–60 | 40–230 | 60–310 | Post-menopausal women: adrenal DHEA-S becomes the primary androgen and oestrogen precursor source (ovaries no longer active). DHEA-S measurement important in post-menopausal androgen evaluation. |
| Ages 61–70 | 25–160 | 40–240 | Continuing decline — adrenopause well established. Low-normal values expected. A value below 40 µg/dL in this age group in women may be associated with symptoms but is not routinely treated unless there are specific indications. |
| Ages 71+ | 15–110 | 25–170 | Deep adrenopause — typical values are 10–20% of peak. Values should always be compared to the age-appropriate reference range on the specific report, not to peak-age ranges. |
| Post-menopause (any age) | 15–170 | Post-menopausal women are evaluated against age-specific ranges. DHEA-S is the predominant circulating androgen precursor in post-menopausal women — peripheral conversion to oestrogens in fat tissue contributes to residual post-menopausal oestrogen levels. | |
- The age-appropriate range is non-negotiable: A DHEA-S of 200 µg/dL is completely normal in a 25-year-old woman and may be mildly low-normal in a 60-year-old woman. Never interpret a DHEA-S value without confirming it against the age-specific reference range on the report.
- Men have higher DHEA-S than women of the same age: Men's DHEA-S is typically 30–50% higher than women's across all age groups. Always compare your result to the same-sex reference range.
- DHEA-S declines significantly in pregnancy: During pregnancy, DHEA-S levels fall substantially (by 30–50%) due to increased metabolic clearance by the placenta, which uses DHEA-S as a substrate for oestrogen synthesis. A low DHEA-S in pregnancy is normal and should not be interpreted against standard non-pregnant reference ranges.
- Oral contraceptive pills reduce DHEA-S: OCP use (very common in Indian women with PCOS) suppresses LH and thereby reduces ovarian androgen production — and also reduces DHEA-S levels by suppressing ACTH. DHEA-S measured while on OCP will be lower than the patient's true baseline. Ideally, DHEA-S should be measured after stopping OCP for 4–12 weeks.
High DHEA-S — Causes & Clinical Significance
The most common cause of mildly to moderately elevated DHEA-S in Indian women of reproductive age is PCOS (polycystic ovary syndrome) with a significant adrenal androgen component. While the ovaries are the primary androgen source in classic PCOS (elevated testosterone and LH:FSH ratio), a subset of PCOS — estimated at 20–30% of all PCOS cases — has substantial adrenal hyperandrogenaemia in addition to ovarian androgen excess. Typically: DHEA-S 1.2–2× the upper limit of normal (e.g., 430–800 µg/dL in a woman whose upper limit is 380). Clinical presentation: hirsutism (unwanted facial and body hair), acne, irregular or absent periods, and often the metabolic features of PCOS (insulin resistance, weight gain). The mechanism: in PCOS, elevated insulin (from insulin resistance) has a specific stimulatory effect on adrenal androgen production — ACTH-independent stimulation of DHEA-S secretion from the zona reticularis. This explains why insulin-sensitising agents (metformin, myo-inositol) not only improve menstrual regularity but also reduce DHEA-S in PCOS patients.
India में most common cause: PCOS with adrenal androgen component। 20–30% PCOS cases में substantial adrenal hyperandrogenaemia। DHEA-S typically 1.2–2× ULN (e.g., 430–800 µg/dL when ULN 380)। Clinical: hirsutism, acne, irregular periods, insulin resistance, weight gain। Mechanism: Elevated insulin (insulin resistance) → ACTH-independent adrenal DHEA-S stimulation। Insulin-sensitising agents (metformin, myo-inositol) → menstrual regularity improve + DHEA-S reduce।Non-classic congenital adrenal hyperplasia (NCAH — also called late-onset CAH) is caused by a partial deficiency of 21-hydroxylase (the enzyme responsible for cortisol synthesis in the adrenal cortex). When cortisol synthesis is partially blocked, the accumulating precursors are shunted into the androgen pathway — producing excess DHEA, androstenedione, and testosterone. NCAH is more common in certain ethnic groups (Ashkenazi Jewish, Hispanic, Southern European, Mediterranean) but is also seen in Indian populations, and is estimated to affect approximately 1–10% of women presenting with hirsutism. Clinically, NCAH mimics PCOS closely — irregular periods, hirsutism, acne, and polycystic-appearing ovaries on ultrasound. Key distinguishing features from PCOS: DHEA-S in NCAH is typically more markedly elevated (often 2–4× ULN), and the 17-OH progesterone level (drawn in the morning in the follicular phase) will be elevated — above 2 ng/mL (basal) or above 10 ng/mL after ACTH stimulation. NCAH is distinguished from classic CAH (which presents in infancy with life-threatening adrenal crisis) by its milder enzyme deficiency. Treatment: low-dose dexamethasone to suppress adrenal androgen production.
NCAH (Non-Classic CAH / Late-Onset CAH): 21-hydroxylase partial deficiency → cortisol synthesis partially blocked → precursors adrenal androgen pathway में shunt → excess DHEA, androstenedione, testosterone। India में seen। ~1–10% hirsutism women। Clinically PCOS जैसा (irregular periods, hirsutism, acne, polycystic ovaries on USG)। DHEA-S in NCAH: typically 2–4× ULN (PCOS से more markedly elevated)। 17-OH progesterone elevated (morning, follicular phase — >2 ng/mL basal, >10 ng/mL post-ACTH)। Classic CAH (infancy, adrenal crisis) से milder। Treatment: low-dose dexamethasone।Adrenal androgen-secreting tumours (adrenocortical carcinoma, adrenocortical adenoma) are rare but important causes of markedly elevated DHEA-S. Key features that distinguish adrenal tumour from functional causes (PCOS, NCAH): the degree of elevation (DHEA-S above 700–800 µg/dL — particularly above 1,000 µg/dL — in an adult woman is more likely from a tumour than from PCOS or NCAH); the rapidity of onset (tumour-related hyperandrogenaemia typically develops rapidly over months, while PCOS-related elevation is usually long-standing); and the associated clinical features (virilisation — clitoral enlargement, deep voice change, male-pattern baldness — which are unusual in PCOS and NCAH but occur in adrenal carcinoma). Investigation: adrenal CT or MRI when DHEA-S is markedly elevated (above 700 µg/dL in adult women, or any level with features of virilisation). Adrenocortical carcinoma is often large at presentation and associated with multiple hormonal abnormalities (cortisol excess causing Cushing syndrome, in addition to androgen excess). Available at major oncology and endocrinology centres in India.
Adrenal androgen-secreting tumours (adrenocortical carcinoma, adenoma): rare but important। Distinguishing features: DHEA-S markedly elevated (>700–800 µg/dL, especially >1,000 µg/dL = tumour more likely than PCOS/NCAH)। Rapid onset (months, not long-standing)। Virilisation (clitoral enlargement, voice change, male-pattern baldness — PCOS/NCAH में unusual)। Investigation: Adrenal CT/MRI (DHEA-S >700 µg/dL adult women, या any level + virilisation features)। Adrenocortical carcinoma: often large, multiple hormonal abnormalities (cortisol excess = Cushing syndrome + androgen excess)।Conditions that elevate ACTH (the primary regulator of adrenal androgen production) will also raise DHEA-S. These include: Cushing disease (ACTH-secreting pituitary adenoma causing excess cortisol and adrenal androgens — DHEA-S is elevated but usually moderate in Cushing disease, as the zona reticularis responds to ACTH alongside the zona fasciculata). Ectopic ACTH syndrome (ACTH from a non-pituitary tumour — lung carcinoid, small cell lung cancer). Severe chronic psychological stress — though the ACTH-DHEA-S relationship during stress is complex and not always linearly predictive. Primary adrenal hyperplasia (bilateral macro- or micronodular adrenal hyperplasia — rare). It is important to note: in adrenocortical carcinoma and adrenal adenoma, DHEA-S is elevated despite normal or low ACTH (the tumour secretes androgens autonomously). This ACTH-independent elevation is a diagnostic pointer toward tumour.
Elevated ACTH states: Cushing disease (ACTH-secreting pituitary adenoma → cortisol + adrenal androgens excess — DHEA-S moderate elevated)। Ectopic ACTH (non-pituitary tumour — lung carcinoid, SCLC)। Severe chronic stress (complex ACTH-DHEA-S relationship)। Primary adrenal hyperplasia (bilateral — rare)। Key: Adrenocortical carcinoma/adenoma = DHEA-S elevated despite normal/low ACTH (autonomous secretion) → ACTH-independent elevation = tumour diagnostic pointer।Low DHEA-S — Causes & Clinical Significance
- Adrenal insufficiency (Addison's disease and other causes): Primary adrenal insufficiency (Addison's disease — autoimmune destruction of the adrenal cortex) causes deficiency of all adrenal steroids including cortisol, aldosterone, and DHEA-S. In India, TB-related adrenal destruction is an important additional cause (TB adrenalitis — the adrenal glands are a not uncommon site of extra-pulmonary TB). Secondary adrenal insufficiency (pituitary disease causing low ACTH) also reduces DHEA-S. In adrenal insufficiency, DHEA-S is uniformly low — often undetectable. Symptoms: fatigue, weight loss, hyperpigmentation (in primary adrenal insufficiency), salt craving, low blood pressure.
- Exogenous corticosteroid use: The most common cause of low DHEA-S in clinical practice in India is exogenous corticosteroid therapy — prednisone, dexamethasone, budesonide, and other steroids suppress ACTH secretion from the pituitary (through negative feedback on the hypothalamic-pituitary-adrenal axis), which in turn suppresses adrenal DHEA-S production. This is an expected side effect of systemic steroid use and is not inherently concerning unless adrenal insufficiency is suspected.
- Hyperprolactinaemia: Elevated prolactin (from pituitary prolactinoma or other causes) suppresses adrenal androgen production — DHEA-S may be mildly reduced in hyperprolactinaemia. This is a relatively minor effect compared to the prolactin-mediated suppression of gonadal function.
- Age-related adrenopause: The most common cause of low DHEA-S in individuals above 60 — an entirely physiological age-related decline. DHEA-S values in the low-normal or below-normal range in elderly patients may represent adrenopause rather than pathological adrenal insufficiency. Clinical judgement and cortisol testing are required to distinguish the two.
- Symptoms possibly associated with low DHEA-S (though evidence for causal role is mixed): Fatigue, reduced libido, decreased sexual desire, vaginal dryness (post-menopausal women), reduced bone mineral density, impaired cognitive function, and depression have all been associated with low DHEA-S in observational studies. Whether DHEA supplementation reliably improves these symptoms in non-adrenal-insufficient individuals is controversial.
DHEA-S in PCOS — India Context
In India, where PCOS affects an estimated 20–30% of women of reproductive age, the hormonal evaluation of PCOS typically includes a multi-hormone panel alongside DHEA-S. FOGSI (Federation of Obstetric and Gynaecological Societies of India) and the Endocrine Society of India recommend the following panel for complete PCOS evaluation:
- LH, FSH, and LH:FSH ratio (see our Female Hormones guide)
- Total testosterone and free testosterone (or free androgen index)
- DHEA-S (the adrenal androgen component — the focus of this guide)
- 17-OH progesterone (morning sample, follicular phase) — to exclude NCAH
- Prolactin (to exclude hyperprolactinaemia mimicking PCOS)
- TSH (to exclude hypothyroidism — which causes menstrual irregularity similar to PCOS)
- Fasting insulin, glucose, HOMA-IR (see our HOMA-IR guide)
- AMH (see our AMH guide)
- Pelvic ultrasound (transvaginal preferred in adults) for ovarian morphology
The DHEA-S result specifically influences treatment strategy in PCOS:
- Elevated DHEA-S + elevated testosterone + insulin resistance (the most common Indian PCOS pattern): First-line treatment is metformin (or myo-inositol + D-chiro-inositol combination — increasingly preferred in India for PCOS management). Insulin sensitisation reduces adrenal androgen production driven by hyperinsulinaemia as well as ovarian androgen production. Weight loss (5–7% body weight) independently reduces DHEA-S and testosterone in obese PCOS patients.
- Elevated DHEA-S + normal testosterone (adrenal-predominant pattern): Consider low-dose dexamethasone (0.25 mg at bedtime — suppresses overnight ACTH and adrenal androgen production). Used cautiously as dexamethasone suppresses the HPA axis. Myo-inositol also useful in this subgroup.
- Normal DHEA-S + elevated testosterone (ovarian-predominant pattern): Combined oral contraceptive pill (OCP) with anti-androgenic progestogen (drospirenone, cyproterone acetate — widely used in India) is the most effective treatment for symptom control (hirsutism, acne, cycle regulation). OCP reduces LH-driven ovarian testosterone production.
- Both elevated (dual-source): Combination approach — metformin/myo-inositol for insulin resistance + OCP for cycle regulation and androgen blockade.
- DHEA-S very markedly elevated (above 700 µg/dL): Rule out adrenal tumour before starting any PCOS treatment.
DHEA-S as Adrenal vs Ovarian Source Marker
| Pattern | DHEA-S | Testosterone | Most Likely Diagnosis |
|---|---|---|---|
| High DHEA-S, Normal Testosterone | High | Normal | Adrenal-predominant androgen excess — PCOS with adrenal component, NCAH (check 17-OH progesterone), adrenal hyperplasia. Consider dexamethasone suppression test. |
| Normal DHEA-S, High Testosterone | Normal | High | Ovarian-predominant androgen excess — classic PCOS (check LH:FSH, LH elevated). Ovarian tumour if testosterone markedly high (>2× ULN) — urgent pelvic ultrasound. |
| Both High DHEA-S and Testosterone | High | High | Dual-source hyperandrogenaemia — PCOS with both ovarian and adrenal components (most complex PCOS subtype, 20–30% of cases). Both sources need to be targeted therapeutically. |
| Normal DHEA-S, Normal Testosterone | Normal | Normal | Biochemical androgen excess excluded. Consider: non-androgenic causes of hirsutism (familial, racial — common in Indian women where constitutional hirsutism is frequent); check prolactin and TSH; review medications (phenytoin, minoxidil, cyclosporin — can cause hirsutism without androgen elevation). |
| Very High DHEA-S (>700–1,000 µg/dL) | Very High | Red flag — urgent adrenal imaging required. Adrenal tumour (carcinoma or adenoma) must be excluded. Also check: cortisol (Cushing), 17-OH progesterone (NCAH), ACTH. Do not start PCOS treatment without completing adrenal investigation at these levels. | |
Test Preparation Checklist / टेस्ट की तैयारी
-
DHEA-S testing does not require fasting and has no significant diurnal variation — it can be collected at any time of day. This is one of the practical advantages of DHEA-S over free DHEA (which has significant infradian pulsatility). However, since DHEA-S is almost always ordered as part of a hormone panel alongside other tests that may have timing requirements (LH, FSH — day 2–5 of cycle; 17-OH progesterone — morning, follicular phase), follow your physician's specific timing instructions for the complete panel.
DHEA-S: fasting required नहीं + significant diurnal variation नहीं → anytime collect। Practical advantage over free DHEA। But usually hormone panel के साथ order (LH, FSH — cycle day 2–5; 17-OH progesterone — morning, follicular phase) → physician की specific timing instructions follow। -
Inform your physician and lab if you are currently taking or have recently taken: oral contraceptive pills (OCP), corticosteroids (prednisone, dexamethasone, budesonide, hydrocortisone), DHEA supplements, or any androgen/anti-androgen medications. All of these significantly affect DHEA-S levels: OCP suppresses DHEA-S (ACTH suppression); corticosteroids suppress DHEA-S; exogenous DHEA supplements will dramatically elevate measured DHEA-S; anti-androgens (spironolactone, flutamide, cyproterone acetate) may suppress DHEA-S indirectly. For the most accurate baseline DHEA-S, ideally stop OCP for 4–12 weeks before testing if medically safe to do so — discuss with your gynaecologist.
Inform physician + lab: OCP (DHEA-S suppress — ACTH suppression)। Corticosteroids (DHEA-S suppress)। DHEA supplements (dramatically elevate measured DHEA-S)। Anti-androgens (spironolactone, flutamide, cyproterone acetate — indirectly suppress)। Accurate baseline: OCP stop 4–12 weeks before testing (if medically safe) — gynaecologist से discuss। -
For PCOS evaluation: the complete hormone panel is best collected on days 2–5 of the menstrual cycle (day 1 = first day of menstrual bleeding). This is specifically important for LH, FSH, and oestradiol. DHEA-S itself does not change significantly across the menstrual cycle, but collecting the full panel at the same time (early follicular phase) provides the most interpretable set of results and avoids repeated visits. If your periods are very irregular or absent (amenorrhoea) — collect at any time, or as directed by your physician.
PCOS evaluation: complete hormone panel = menstrual cycle days 2–5 (day 1 = menstrual bleeding का first day) best। LH, FSH, oestradiol के लिए specifically important। DHEA-S itself menstrual cycle across significantly change नहीं — लेकिन full panel same time (early follicular) = most interpretable। Very irregular/absent periods: anytime collect, या physician के direction। -
Always use the age-appropriate reference range on your specific lab report for interpreting DHEA-S. A DHEA-S of 110 µg/dL is well within normal for a 55-year-old woman but would be below normal for a 25-year-old woman. Never compare your value against the wrong age group's range. If your report does not clearly show an age-specific reference range, ask your lab or physician to confirm which range applies to your age.
DHEA-S interpretation: specific lab report का age-appropriate reference range use करें। 110 µg/dL = 55-year-old में well within normal, 25-year-old में below normal। Wrong age group range से compare नहीं। Report में age-specific range clearly नहीं है → lab या physician से confirm।
Adrenal insufficiency evaluation: DHEA-S + morning cortisol (8–9 AM fasting) साथ collect। Morning cortisol <3 µg/dL + very low DHEA-S = highly suggestive। Cortisol 3–18 µg/dL range: Synacthen/ACTH stimulation test (definitive adrenal reserve)।
✅ Book DHEA-S Test — Home Collection Available
For PCOS evaluation, book DHEA-S alongside LH, FSH, Testosterone, 17-OH Progesterone, Prolactin, TSH, fasting insulin, AMH, and HOMA-IR. Collect days 2–5 of cycle. No fasting required for DHEA-S alone. Inform lab of OCP, corticosteroid, or DHEA supplement use. For adrenal insufficiency evaluation, add morning cortisol (8–9 AM fasting):
Affiliate link: I may earn a small commission at no extra cost to you. DHEA-S testing is available at government hospitals and NABL-accredited labs across India. Always have results interpreted by a qualified gynaecologist, endocrinologist, or physician alongside clinical symptoms, physical examination, and other hormone panel results. Never self-diagnose PCOS, adrenal insufficiency, or adrenal tumour based on a single DHEA-S test result. Do not self-prescribe DHEA supplements — DHEA is a hormone and can cause androgen excess in women (acne, hirsutism, voice changes).
DHEA-S testing government hospitals + NABL labs। PCOS evaluation: days 2–5 cycle। Medications inform। Gynaecologist/endocrinologist से interpret — symptoms + examination + full hormone panel। PCOS/adrenal insufficiency/tumour self-diagnose नहीं। DHEA supplements self-prescribe नहीं — androgen excess (acne, hirsutism, voice changes)।Adrenal & Hormonal Health Support
Two products relevant to adrenal and hormonal health — an adaptogenic Ashwagandha supplement (one of the best-studied adaptogens for HPA axis (hypothalamic-pituitary-adrenal axis) regulation, with specific evidence for modulating the stress-cortisol-ACTH response that directly regulates adrenal DHEA-S production, and for improving insulin sensitivity — both mechanisms relevant to PCOS and adrenal androgen management in India) and a DHEA supplement (for documented adrenal insufficiency or adrenopause-related DHEA deficiency under physician supervision — DHEA supplementation is FDA-recognized as a hormone and should never be self-prescribed). These products are not treatments for PCOS, adrenal insufficiency, or adrenal tumours. DHEA supplementation in women with PCOS who already have elevated DHEA-S is contraindicated and will worsen androgen excess symptoms. Always consult an endocrinologist or gynaecologist before starting either product if you have a diagnosed hormone condition.
Ashwagandha (Withania somnifera) is one of the most extensively studied Ayurvedic medicinal plants in modern clinical research, with a specific evidence base for modulating the HPA (hypothalamic-pituitary-adrenal) axis — the regulatory system that controls cortisol and DHEA-S production. This mechanism is directly relevant to two major Indian patient populations: stressed adults with adrenal dysregulation (where chronic psychological and physiological stress drives abnormal ACTH and cortisol rhythms, with downstream effects on DHEA-S and the DHEA:cortisol ratio) and PCOS patients with insulin resistance (where Ashwagandha's well-documented insulin-sensitising effects may reduce the hyperinsulinaemia that drives adrenal androgen excess). The mechanistic basis: Ashwagandha's primary active constituents — withanolides (particularly withaferin A and withanolide D) — have been shown in multiple human trials to significantly reduce serum cortisol levels (mean reduction approximately 14–27.9% vs placebo in randomised controlled trials), reduce hair cortisol concentration (a measure of chronic stress exposure), improve thyroid function (relevant to PCOS patients where thyroid dysfunction co-exists), and improve insulin sensitivity in type 2 diabetes patients. A 2019 double-blind RCT (Chandrasekhar et al., Indian Journal of Psychological Medicine) found significant cortisol reduction in chronically stressed adults. Regarding DHEA-S: the relationship between Ashwagandha and DHEA-S is complex — some studies suggest that by reducing chronic cortisol excess and improving ACTH rhythmicity, Ashwagandha may support healthier DHEA-S levels (preventing cortisol-dominant states that suppress DHEA-S). Additionally, Ashwagandha's insulin-sensitising effect may reduce hyperinsulinaemia-driven adrenal androgen production in PCOS — potentially contributing to modest DHEA-S reduction. The Himalaya formulation uses standardised Ashwagandha root extract — standardised for withanolide content — providing consistent bioactive compound delivery in each capsule. Important: Ashwagandha is generally well-tolerated. However, it should be avoided in thyroid conditions requiring medication (hyperthyroidism — may potentiate thyroid hormone effect), in pregnancy, and in patients on immunosuppressants. In PCOS patients with elevated DHEA-S, Ashwagandha alone will not normalise DHEA-S — it is a supportive supplement alongside physician-directed treatment.
Ashwagandha (Withania somnifera): HPA axis modulate करने का most extensive evidence। India में relevance: Stressed adults (chronic stress → abnormal ACTH/cortisol rhythms → DHEA-S और DHEA:cortisol ratio downstream effects)। PCOS + insulin resistance (insulin-sensitising effects → hyperinsulinaemia reduce → adrenal androgen excess कम)। Mechanism: withanolides (withaferin A, withanolide D) → cortisol 14–27.9% reduce (RCTs)। Thyroid function improve। Insulin sensitivity improve। DHEA-S: cortisol excess reduce → healthier DHEA-S levels support। Hyperinsulinaemia reduce → adrenal androgen production कम (modest DHEA-S reduction)। Himalaya: standardised root extract, consistent withanolide delivery। Avoid: thyroid medication (hyperthyroidism), pregnancy, immunosuppressants। PCOS elevated DHEA-S में: Ashwagandha alone DHEA-S normalise नहीं — physician-directed treatment के साथ supportive supplement। View on Amazon IndiaAffiliate link — small commission at no extra cost.
DHEA supplementation is a legitimate and well-studied therapeutic intervention — but in strictly specific, physician-supervised contexts. It is critical to understand when DHEA supplementation is appropriate and when it is absolutely contraindicated, before considering this product. Appropriate contexts for physician-supervised DHEA supplementation: documented adrenal insufficiency (where the adrenal glands cannot produce adequate DHEA-S — Addison's disease, secondary adrenal insufficiency following long-term steroid use, or bilateral adrenalectomy). In these patients, DHEA replacement (25–50 mg/day in women, 50 mg/day in men) is a recognised component of comprehensive adrenal hormone replacement that meaningfully improves quality of life, libido, and energy — and is supported by multiple RCTs and endorsed by the Endocrine Society's guidelines on adrenal insufficiency. Severe adrenopause in elderly individuals with documented very low DHEA-S and significant symptoms (fatigue, reduced libido, reduced bone mineral density) — though the evidence for benefit in non-adrenal-insufficient elderly individuals is less consistent. Systemic lupus erythematosus (SLE/lupus) — where DHEA supplementation has FDA recognition as an adjunctive treatment (prasterone/Prestara). What DHEA supplementation is NOT appropriate for: PCOS patients with already elevated or high-normal DHEA-S (supplementation will worsen androgen excess — more acne, worse hirsutism, potential voice deepening); women without documented DHEA-S deficiency who want to "boost hormones" or "anti-age"; any patient without physician evaluation of their DHEA-S level first. The 50 mg dose is the typical starting dose for men in adrenal insufficiency; women with adrenal insufficiency typically start at 25 mg (half of one capsule) due to the greater androgenic sensitivity of women to DHEA-derived testosterone. Always measure DHEA-S 4–8 weeks after starting supplementation to confirm adequate but not excessive response. DHEA is a prohormone — not a vitamin or nutraceutical. In India, it is not yet scheduled as a prescription drug but should be treated as one. Never self-supplement without confirmed DHEA-S deficiency and physician guidance. In women of reproductive age, DHEA supplementation can cause significant androgenic side effects (acne, hirsutism, clitoral enlargement, voice deepening) and can disrupt the menstrual cycle.
DHEA supplementation: specific, physician-supervised contexts में appropriate। Appropriate: Documented adrenal insufficiency (Addison's, secondary adrenal insufficiency, bilateral adrenalectomy) — 25–50 mg/day women, 50 mg/day men। Multiple RCTs + Endocrine Society guidelines support। Quality of life, libido, energy meaningfully improve। Severe adrenopause (very low DHEA-S + significant symptoms — elderly)। SLE (FDA recognition)। NOT appropriate: PCOS elevated/high-normal DHEA-S patients (worsen androgen excess — acne worse, hirsutism worse, potential voice deepening)। Women without documented deficiency। DHEA-S level physician evaluation पहले। 50 mg = men में typical starting dose। Women: 25 mg start (androgenic sensitivity higher)। 4–8 weeks बाद DHEA-S measure। DHEA = prohormone, vitamin नहीं। Confirmed DHEA-S deficiency + physician guidance without = never supplement। Reproductive age women में significant androgenic side effects। View on Amazon IndiaAffiliate link — small commission at no extra cost.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside DHEA-S for complete hormonal and PCOS evaluation:
DHEA-S के साथ ये जांचें complete hormonal और PCOS evaluation में order होती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
A DHEA-S of 498 µg/dL against an upper limit of 380 µg/dL represents a mild to moderate elevation — approximately 1.3 times the upper limit of normal. In the context of known PCOS, this degree of DHEA-S elevation is very commonly seen and in most cases reflects the adrenal androgen component of PCOS rather than anything more serious. The priorities for investigation: First, ensure active adrenal pathology is excluded — specifically non-classic congenital adrenal hyperplasia (NCAH). A morning 17-OH progesterone test (collected in the follicular phase, fasting) should be done alongside your DHEA-S panel. If 17-OH progesterone is below 2 ng/mL, NCAH is very unlikely. Second, as DHEA-S is only mildly elevated (not markedly elevated — which would be above 700–800 µg/dL), adrenal imaging is not routinely required at this level unless there are other concerning features (rapid symptom onset, virilisation). Third, the degree of elevation (1.3× ULN) is unlikely to require adrenal-specific treatment in isolation — the primary PCOS management (metformin or myo-inositol for insulin resistance, OCP with anti-androgenic progestogen for symptom control) will typically also reduce DHEA-S. DHEA-S should be rechecked 6–12 months after starting PCOS treatment to assess response. Discuss the full picture with your gynaecologist or endocrinologist.
उत्तर: 498 µg/dL vs ULN 380 = mild to moderate elevation (~1.3× ULN)। Known PCOS में very commonly seen = adrenal androgen component। Investigation priorities: 1. NCAH exclude: morning 17-OH progesterone (follicular phase, fasting)। <2 ng/mL = NCAH very unlikely। 2. Mildly elevated (not markedly, >700–800 µg/dL) → adrenal imaging not routinely required। 3. 1.3× ULN = adrenal-specific treatment alone unlikely needed। Primary PCOS management (metformin/myo-inositol + OCP) typically DHEA-S भी reduce। 6–12 months बाद recheck। Gynaecologist/endocrinologist से discuss।DHEA (Dehydroepiandrosterone) is the free, unconjugated form of the hormone — biologically active but present in the blood at very low concentrations (nanomolar levels) with a very short half-life of approximately 20–30 minutes. This makes it very difficult to measure reliably — blood DHEA levels fluctuate dramatically throughout the day in a pulsatile pattern. DHEA-S (DHEA sulphate) is the sulphate-conjugated form — produced when the enzyme DHEA sulphotransferase (SULT2A1) in the adrenal gland and liver adds a sulphate group to DHEA. DHEA-S is water-soluble, circulates bound to albumin, has a half-life of approximately 8–11 hours, and is present in the blood at concentrations 100–500 times higher than free DHEA. These properties make DHEA-S far more stable, more measurable, and more reliably representative of the body's adrenal androgen production. In routine clinical practice, when a doctor orders a "DHEA test" or a "DHEA-S test" — they almost always mean DHEA-S. Confirm by checking your lab report: if it shows values in µg/dL (typically in the range of 50–600 for adults), it is measuring DHEA-S. If you truly need free DHEA measured (a research or specialist scenario), the test will specifically state "free DHEA" or "unconjugated DHEA."
उत्तर: DHEA = free unconjugated form — biologically active, very low concentrations (nanomolar), half-life ~20–30 min, pulsatile fluctuations। Reliably measure करना difficult। DHEA-S = sulphate-conjugated form (SULT2A1 enzyme द्वारा)। Water-soluble, albumin-bound, half-life ~8–11 hours, 100–500× higher than free DHEA। Far more stable + measurable + representative। Routine clinical practice: "DHEA test" = almost always DHEA-S। Confirm: µg/dL range (50–600 adults) = DHEA-S। Free DHEA specific research/specialist scenario — report specifically "free DHEA" / "unconjugated DHEA" state करेगा।Not necessarily — low DHEA-S for age has several causes, and adrenal insufficiency is only one of them. The most common cause of low DHEA-S in Indian clinical practice is exogenous corticosteroid use — if you are on or have recently taken prednisone, dexamethasone, betamethasone, methylprednisolone, or even long-term inhaled budesonide at high doses, this will suppress your adrenal DHEA-S production. The second most common cause is oral contraceptive pill use, which suppresses ACTH and therefore DHEA-S. Age-related adrenopause (physiological decline) is the most common cause in individuals above 60. True adrenal insufficiency (Addison's disease or secondary adrenal insufficiency) typically presents with additional features — fatigue, weight loss, low blood pressure, salt craving, hyperpigmentation (in primary adrenal insufficiency), hypoglycaemia — alongside low DHEA-S and critically low morning cortisol. If you have a very low DHEA-S AND a very low morning cortisol (below 3 µg/dL), adrenal insufficiency is the primary concern. If you have low DHEA-S but a normal morning cortisol, isolated DHEA-S deficiency (adrenopause) or medication-related suppression is more likely. Discuss with your endocrinologist, who can arrange a Synacthen stimulation test (ACTH stimulation test) if adrenal insufficiency is suspected.
उत्तर: Necessarily नहीं। Most common causes India में: Exogenous corticosteroids (prednisone, dexamethasone, high-dose inhaled budesonide → DHEA-S suppress)। OCP use (ACTH suppress → DHEA-S suppress)। Age-related adrenopause (>60 में physiological)। True adrenal insufficiency: additional features + critically low morning cortisol। Very low DHEA-S + very low morning cortisol (<3 µg/dL) = adrenal insufficiency primary concern। Low DHEA-S + normal morning cortisol = adrenopause या medication-related। Endocrinologist से discuss → Synacthen stimulation test (ACTH stimulation) if adrenal insufficiency suspect।No — absolutely not, unless specifically prescribed by an endocrinologist after confirmed DHEA-S deficiency testing. In PCOS, the problem is that androgens (including DHEA-S and testosterone) are already too high — not too low. Taking DHEA supplements when you already have elevated or even high-normal DHEA-S will significantly worsen androgen excess symptoms: more acne, more unwanted hair growth (hirsutism), potentially irregular periods worsening, and in some cases, voice deepening or clitoral enlargement at higher doses. This is the opposite of what PCOS management aims to achieve. DHEA supplementation is only indicated when DHEA-S is documented to be deficient — well below the age-appropriate lower limit — which is almost never the case in a premenopausal woman with PCOS. The misleading idea that "DHEA balances hormones" in PCOS is a common misconception promoted by wellness marketing — it is biologically incorrect for PCOS patients. If your PCOS hormonal evaluation shows elevated DHEA-S, the appropriate treatment is directed at reducing adrenal androgen production (through insulin sensitisation with metformin or myo-inositol, weight management, and in specific cases low-dose dexamethasone) — not supplementing with more DHEA.
उत्तर: Absolutely not — unless endocrinologist से confirmed DHEA-S deficiency testing के बाद specifically prescribed। PCOS में problem: androgens (DHEA-S + testosterone) already too high — too low नहीं। DHEA supplements लेना = androgen excess symptoms worsen: more acne, more hirsutism, irregular periods worsen, potentially voice deepening/clitoral enlargement। PCOS management का opposite। DHEA supplementation: only when DHEA-S documented deficient (age-appropriate lower limit से well below) — premenopausal PCOS woman में almost never। "DHEA balances hormones in PCOS" = misleading wellness marketing misconception — biologically incorrect for PCOS। Elevated DHEA-S in PCOS: appropriate treatment = adrenal androgen production reduce (metformin/myo-inositol, weight management, specific cases में low-dose dexamethasone) — more DHEA supplement नहीं।A DHEA-S above 700 µg/dL (and particularly above 1,000 µg/dL) in an adult woman is a red-flag result that requires urgent specialist evaluation to exclude an adrenal tumour. While PCOS and NCAH can cause elevated DHEA-S, they rarely cause values above 700 µg/dL — this degree of elevation should not be attributed to PCOS without first excluding adrenal pathology. The immediate next steps are: (1) Urgent referral to an endocrinologist. (2) Adrenal imaging — CT scan of the abdomen (adrenal protocol) or MRI to look for an adrenal mass. (3) Additional hormonal investigations: 24-hour urine cortisol or overnight dexamethasone suppression test (to screen for Cushing syndrome — cortisol excess); ACTH level (low ACTH with very high DHEA-S suggests autonomous adrenal tumour secretion); testosterone total; 17-OH progesterone (to exclude NCAH). (4) If an adrenal tumour is identified, specialist oncological and surgical evaluation at a tertiary centre. If all adrenal imaging is normal and additional hormones are not severely abnormal, the diagnosis of PCOS with particularly marked adrenal hyperandrogenaemia or NCAH can be considered — but only after adrenal tumour has been definitively excluded. Do not delay specialist evaluation based on a previous PCOS diagnosis — very high DHEA-S warrants independent investigation.
उत्तर: DHEA-S >700 µg/dL (especially >1,000) = RED FLAG — urgent specialist evaluation, adrenal tumour exclude। PCOS/NCAH rarely cause >700 µg/dL — PCOS label based पर assume नहीं। Immediate next steps: 1. Urgent endocrinologist referral। 2. Adrenal CT (adrenal protocol) या MRI — adrenal mass। 3. Additional: 24-hour urine cortisol/overnight DST (Cushing screen)। ACTH level (low ACTH + very high DHEA-S = autonomous adrenal tumour)। Total testosterone। 17-OH progesterone (NCAH)। 4. Adrenal tumour identified: tertiary centre oncological + surgical evaluation। Normal adrenal imaging + not severely abnormal additional hormones → PCOS with marked adrenal hyperandrogenaemia या NCAH consider — but only after adrenal tumour definitively excluded। Previous PCOS diagnosis के बाद भी: very high DHEA-S = independent investigation।- Endocrine Society — PCOS Clinical Practice Guidelines: Endocrine Society — Androgen Deficiency in Women Guidelines
- FOGSI India — PCOS Management Guidelines: FOGSI — Federation of Obstetric & Gynaecological Societies of India
- MedlinePlus (NIH) — DHEA-S Test Information: DHEA-S Test — Patient Information
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. DHEA-S results must be interpreted by a qualified gynaecologist, endocrinologist, or physician alongside clinical symptoms, physical examination, complete hormone panel (LH, FSH, testosterone, 17-OH progesterone, prolactin, TSH), and adrenal imaging where indicated. A very high DHEA-S (above 700 µg/dL) requires urgent specialist evaluation to exclude adrenal tumour before any other diagnosis is attributed. Do NOT self-supplement with DHEA without confirmed deficiency and physician prescription — in women of reproductive age with PCOS, DHEA supplementation worsens androgen excess. The DHEA supplement listed in this post is for documented adrenal insufficiency or severe adrenopause under physician supervision ONLY.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। DHEA-S results को gynaecologist/endocrinologist से symptoms + examination + complete hormone panel + adrenal imaging के साथ interpret। Very high DHEA-S (>700 µg/dL) = urgent specialist evaluation → adrenal tumour exclude। Confirmed deficiency + physician prescription के बिना DHEA supplement self-supplement नहीं। PCOS reproductive age women में = androgen excess worsen। DHEA supplement: documented adrenal insufficiency या severe adrenopause, physician supervision ONLY।
Comments
Post a Comment